Global Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Global Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Global Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe, China, Japan, South Korea, India, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030

Market Definition:

Throat cancer is a type of cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Throat cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of throat cancer. Most throat cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales), also called pharyngeal cancer.

Symptoms include cough, changes in voice, such as hoarseness or not speaking clearly, difficulty swallowing, ear pain, a lump or sore that doesn't heal, a sore throat, and weight loss. These symptoms often don't appear until the cancer is advanced. Treatments vary but may include surgery, chemotherapy, radiation therapy, targeted drug therapy, and immunotherapy.

Market Segmentation:

Global throat cancer diagnostics market is categorized into seven notable segments such as product type, test type, cancer type, stages, age group, end user, and distribution channel.
• On the basis of product type, the market is segmented into instruments and consumables & accessories
• On the basis of test type, the market is segmented into imaging tests, biopsy, blood tests, and others
• On the basis of cancer type, the market is segmented into pharyngeal cancer and laryngeal cancer
• On the basis of stages, the market is segmented into stage 0, stage I, stage II, stage III, and stage IV
• On the basis of age group, the market is segmented into below 21, 21-29, 30-65, 65, and above
• On the basis of end user, the market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others
• On the basis of distribution channel, the market is segmented into direct tender and retail sales

Market Players

Some of the major players operating in the global throat cancer diagnostics market are:
• F. Hoffmann-La Roche Ltd.
• FUJIFILM Corporation
• Thermo Fisher Scientific Inc.
• CANON MEDICAL SYSTEMS CORPORATION
• Koninklijke Philips N.V.
• Merck KGaA
• BD
• General Electric Company
• Illumina
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott
• QIAGEN
• Siemens Healthcare GmbH
• Myriad Genetics Inc.
• Quest Diagnostics Incorporated
• Hologic
• FONAR Corp.
• Time Medical Holding.
• Medonica Co. LTD
• SternMed GmbH.
• MinFound Medical Systems Co., Ltd
• PlexBio.
• Beijing O&D Biotech Co., Ltd.